a16z Podcast | Players and Paths for Healthcare Startups

TL;DR

Founders need to adjust their plans for bringing a new drug or process to market, considering go-to-market models and players involved.

Transcript

welcome to the a 16z podcast today we're having another of our hallway style conversations these episodes are based on a videos that are also available on our youtube channel youtube.com slash c /a 16z videos what's the path to success in the world of healthcare startups bio team general partners Jorge Conde and Vijay Pandey discuss how founders ne... Read More

Key Insights

• 😀 Healthcare startups face a complicated landscape that requires adjusting plans and go-to-market strategies.
• 🫠 Biotech unicorns like Adam ad have succeeded by providing transformative tools and partnering with multiple companies.
• 😌 Illumina's success lies in making full-scale, affordable genome sequencing possible.
• 🗯️ Determining the right go-to-market strategy should be based on the technology's applicability, such as diagnostics or drug development.

Questions & Answers

Q: What are the key steps involved in developing healthcare technology?

Developing healthcare technology requires discovering something relevant, gaining regulatory approval, finding funding, educating the healthcare system, and obtaining patient acceptance. Each step is essential for success.

Q: What are the different paths startups can take in the healthcare industry?

Startups can choose to develop their own drugs or diagnostics, going through the lengthy process of clinical trials and approvals. Alternatively, they can empower the industry by providing transformative technologies and partnering with existing players.

Q: How can startups in the healthcare space get regulatory approval?

Regulatory approval for therapies requires going through sequential clinical trials, proving effectiveness in cells and animals. Diagnostic startups can follow a less risky path by obtaining FDA clearance for laboratory-driven tests.

Q: What is the advantage of developing technology for the R&D industry in healthcare?

Selling technology to the R&D industry allows startups to explore multiple avenues and tap into a $75 billion annual industry. It provides a non-aggressive approach and offers more flexibility in targeting different players.

Summary & Key Takeaways

• Developing healthcare technology involves a complex process, including discovering something relevant for human health, gaining regulatory approval, finding funding, educating the healthcare system, and obtaining patient acceptance.

• Two main paths for startups are developing their own drugs/diagnostics or empowering the industry to make better drugs/diagnostics.

• Engineering transformative technologies can convince players in the industry to provide value and create successful go-to-market strategies.